Glaxosmithkline Pharmaceuticals Ltd
BSE : 500660
NSE : GLAXO
Sector :Health care
ISIN Code : INE159A01016
NSE
1393.90
2.95 (0.21%)
BSE
1393.95
4.10 (0.29%)
Glaxosmithkline Pharmaceuticals Ltd
- NSE
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Statistics Overview
M.cap
23614.91
Volume
5670
52-Week High
1562.40
52-Week Low
1228.00
EPS-TTM
1393.95
P/E Ratio
38.97
P/B Ratio
13.47
Book Value Share
103.48
Face Value
10
Dividend Date
30 Jun 2023
Dividend Yield
2.30
- Overview
F & O Quote
- Futures
- OPTIONS
Share Price Returns
Stock Absolute Returns
Sensex Absolute Returns
Stock Strength
| Today's Low/High | 1381.75  1415.00 |
| Week Low/High | 1287.00 1415.00 |
| Month Low/High | 1242.00 1415.00 |
| YEAR Low/High | 1228.00 1562.00 |
| All TIME Low/High | 12.88 1925.00 |
News
View MoreAnnouncement
View MoreFinancials
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow Statement
- Ratios
- Income Statement
- Graph
- Table
- Revenue (Rs Crore)
- Net Profit (Rs Crore)
- Operating Income (Rs Crore)
- Employee Pension Scheme
- Book Value of Equity Per Share
- Return on Equity
- Net Profit Margin
Bulk/ Block
- ALL
- NSE
- BSE
- ALL
- BUY
- SELL
| Date | Client Name | Exchange | Transaction | Quantity | Price |
|---|---|---|---|---|---|
| 17-10-2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | BSE | SELL | 80615 | 1378.65 |
| 17-10-2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | BSE | BUY | 80615 | 1378.65 |
| 17-10-2022 | ISHARES INDIA SC MAURITIUS COMPANY | BSE | SELL | 11841 | 1378.65 |
| 17-10-2022 | ISHARES MSCI INDIA SMALL-CAP ETF | BSE | BUY | 11841 | 1378.65 |
| 11-10-2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | BSE | SELL | 77734 | 1393.45 |
| 11-10-2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | BSE | BUY | 77734 | 1393.45 |
| 11-10-2022 | ISHARES INDIA SC MAURITIUS COMPANY | BSE | SELL | 11417 | 1393.45 |
| 11-10-2022 | ISHARES MSCI INDIA SMALL-CAP ETF | BSE | BUY | 11417 | 1393.45 |
| 19-09-2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | BSE | SELL | 72154 | 1431.75 |
| 19-09-2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | BSE | BUY | 72154 | 1431.75 |
Peer Group Comparison
- Stock Performance
- Ratio Performance
- Graph
- Table
| Date | Price (X) |
|---|
Shareholding Pattern
- Total shareholdings
- Graph
- Table
| Category | Share(%) |
|---|---|
| Promoter | 75.00 |
| Financial Institutions Banks | 0.01 |
| Foreign Institutional Investors | 2.28 |
| Insurance Companies | 6.29 |
| Mutual Funds Uti | 3.96 |
| Indian Public | 10.55 |
| Custodians | 0.00 |
| Other | 1.88 |
Corporate Action
| Announcement Date | Purpose | From | To | Remarks |
|---|
Price History
Search for Price History
Export to Excel- NSE
- BSE
| Date | Open | High | Low | Close | Shares | Trades |
|---|
Load more
Company Info
Company Information
Independent Director : D Sundaram
Company Sec. & Compli. Officer : A A Nadkarni
Independent Director : P V Bhide
Independent Director : A N Roy
Director : Subesh Williams
Chairperson : Renu S Karnad
Independent Director : Sunita Maheshwari
Addtnl Independent Director : Manu Anand
Managing Director : Bhushan Akshikar
Registered Office: GSK House, Dr Annie Besant Road Worli,Mumbai,Maharashtra-400030 Ph: 91-022-24959595
Email:askus@gsk.com
